Research and Markets (http://www.researchandmarkets.com/research/5f7559b9/durable_medical_eq) has announced the addition of the "Durable Medical Equipment: U.S. Market Size, Growth and Trends" report to their offering.
Durable medical equipment (DME) is defined as instruments and products used for medical purposes and that can withstand repeated usage. DME is used primarily to help improve the quality of life of patients with injuries or illnesses.
Different stakeholders segment DME in different ways, making the market more or less inclusive. For the purpose of this report, the authors divided the DME market in six therapeutic segments:
- Home respiratory therapy
- Home infusions
- Diabetes supplies
- Patient positioning
- Patient mobility
- Other equipment
Using this segmentation, it is estimated that the U.S. DME market reached ~$27B in 2009 and is market to grow 6% per annum to $34B by 2013, with various segments growing in the mid- to high- single-digits. This report reviews the factors that will be driving and moderating this growth, such as patient satisfaction, outcome and cost.
DME products are distributed primarily by national and local providers; other channels, such as 3rd party distributors or mail-in orders exist for some channels.
Regardless of segmentation, the market appears highly fragmented. This report reviews the consequences of this fragmentation for manufacturers, providers and payors, and highlight specific segments that appear less fragmented. This report discusses each segment and provides a detailed analysis of home respiratory therapy and patient mobility. For these two segments, the authors review key products, specific growth drivers and moderators, value chain, as well as manufacturer and provider economics in more details. This report examines how reimbursement for oxygen tanks and standard wheelchairs spreads between manufacturers and providers.
Finally, this report provides an analysis of four key events that may transform the industry, and discuss their likelihood. First, it discusses the entry of large new players in new therapeutic segments. Second, it evaluates potential levers for private payors, given their increased scrutiny in this industry, and how they may control costs by negotiating with patients, physicians/hospitals and manufacturers. Third, this report assesses the potential impact of value chain disintermediation. Fourth, it discusses the status of patient discharge and referral laws.
Key Topics Covered:
- Segment analysis: Respiratory therapy
- Segment analysis: Patient mobility
- Future market trends
For more information visit http://www.researchandmarkets.com/research/5f7559b9/durable_medical_eq.